Clinical trial
Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic…
NCT00371033 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00371033 |
|---|---|
| Title | Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) |
| Official title | A Randomized, Placebo-controlled Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Pregabalin for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) |
| Acronym | CPCRN RCT#2 |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) |
| Intervention type | Drug |
| Interventions | Pregabalin, Placebo |
| Enrollment | 324 |
| Start date | Mar 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Apr 30, 2008 |
| First posted | Sep 1, 2006 |
| Last update posted | Sep 22, 2025 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: